144 related articles for article (PubMed ID: 8872173)
21. Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.
Hunt HD; Munitz TI; Pease LR
J Exp Med; 1992 Mar; 175(3):821-9. PubMed ID: 1371305
[TBL] [Abstract][Full Text] [Related]
22. The relationship between MHC restricted and allospecific T cell recognition.
Lechler R; Batchelor R; Lombardi G
Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
[TBL] [Abstract][Full Text] [Related]
23. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
[TBL] [Abstract][Full Text] [Related]
24. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
25. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
26. Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction.
Enssle KH; Wagner H; Fleischer B
Hum Immunol; 1987 Feb; 18(2):135-49. PubMed ID: 2435685
[TBL] [Abstract][Full Text] [Related]
27. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
28. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells.
Kabelitz D
Cell Immunol; 1989 Jul; 121(2):298-305. PubMed ID: 2525425
[TBL] [Abstract][Full Text] [Related]
29. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
30. A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules.
Kievits F; Ivanyi P
J Exp Med; 1991 Jul; 174(1):15-9. PubMed ID: 1905337
[TBL] [Abstract][Full Text] [Related]
31. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
33. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
Speiser DE; Löliger CC; Siren MK; Jeannet M
Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
[TBL] [Abstract][Full Text] [Related]
34. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
35. Variations in the T-cell repertoire against HLA antigens in humans.
Breur-Vriesendorp BS; Vingerhoed J; Schaasberg WP; Ivanyi P
Hum Immunol; 1990 Jan; 27(1):1-15. PubMed ID: 1689283
[TBL] [Abstract][Full Text] [Related]
36. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
37. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
Kim CJ; Parkinson DR; Marincola F
J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
[TBL] [Abstract][Full Text] [Related]
38. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
39. Frequency, specificity, and phenotype of clonally growing human alloreactive interleukin-2-secreting helper T lymphocyte precursors.
Theobald M; Hoffmann T; Bunjes D; Heit W
Transplantation; 1990 Nov; 50(5):850-6. PubMed ID: 2146786
[TBL] [Abstract][Full Text] [Related]
40. Effect of one-HLA-haplotype-matched and HLA-mismatched blood transfusions on recipient T lymphocyte allorepertoires.
Young NT; Roelen DL; Iggo N; Gray DW; Roake JA; Graham V; Wood KJ; Dallman MJ; Welsh KI; Morris PJ
Transplantation; 1997 Apr; 63(8):1160-5. PubMed ID: 9133479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
